Today's After-Hours Movers:

Sutro Biopharma, Inc. (NASDAQ: STRO) 16.1% HIGHER; provided a clinical update from the company's ongoing dose-escalation Phase 1 study of STRO-002, a folate receptor alpha (FolR) targeting antibody-drug conjugate (ADC), for patients with ovarian cancer.

PagerDuty, Inc. (NYSE: PD) 13.6% HIGHER; reported Q3 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $54 million versus the consensus estimate of $52.54 million. PagerDuty, Inc. sees Q4 2021 EPS of ($0.12)-($0.11), versus the consensus of ($0.10). PagerDuty, Inc. sees Q4 2021 revenue of $57-58 million, versus the consensus of $55.6 million. PagerDuty, Inc. sees FY2021 EPS of ($0.30)-($0.29), versus the consensus of ($0.29). PagerDuty, Inc. sees FY2021 revenue of $211-212 million, versus the consensus of $208.7 million.

Yext, Inc. (NYSE: YEXT) 11% LOWER; reported Q3 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $89.1 million versus the consensus estimate of $87.19 million. Yext, Inc. sees Q4 2021 EPS of ($0.10)-($0.08), versus the consensus of ($0.08). Yext, Inc. sees Q4 2021 revenue of $87-89 million, versus the consensus of $94.04 million.

Ollie's Bargain Outlet (NASDAQ: OLLI) 9.5% LOWER; reported Q3 EPS of $0.65, $0.07 better than the analyst estimate of $0.58. Revenue for the quarter came in at $414.4 million versus the consensus estimate of $406.06 million.

Medallia (NYSE: MDLA) 9% LOWER; reported Q3 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $121 million versus the consensus estimate of $116.91 million. Medallia sees Q4 2021 revenue of $123.5-125.5 million, versus the consensus of $122.83 million.

Cloudera, Inc. (NYSE: CLDR) 8% HIGHER; reported Q3 EPS of $0.15, $0.06 better than the analyst estimate of $0.09. Revenue for the quarter came in at $217.9 million versus the consensus estimate of $209.16 million. Cloudera, Inc. sees Q4 2021 EPS of $0.10-$0.12, versus the consensus of $0.10. Cloudera, Inc. sees Q4 2021 revenue of $219-222 million, versus the consensus of $215.69 million. Cloudera, Inc. sees FY2021 EPS of $0.40-$0.42, versus the consensus of $0.33. Cloudera, Inc. sees FY2021 revenue of $862-865 million, versus the consensus of $849.8 million.

DocuSign Inc. (NASDAQ: DOCU) 6.5% HIGHER; reported Q3 EPS of $0.22, $0.09 better than the analyst estimate of $0.13. Revenue for the quarter came in at $382.9 million versus the consensus estimate of $361.15 million. DocuSign Inc. sees Q4 2021 revenue of $404-408 million, versus the consensus of $387.3 million.

Marvell Technology (NASDAQ: MRVL) 4.6% LOWER; reported Q3 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $750 million versus the consensus estimate of $750.97 million. Marvell Technology sees Q4 2021 EPS of $0.25-$0.33, versus the consensus of $0.29. Marvell Technology sees Q4 2021 revenue of $745.75-824.25 million, versus the consensus of $787.41 million.

Zuora, Inc. (NYSE: ZUO) 4.5% HIGHER; reported Q3 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $77.2 million versus the consensus estimate of $73.92 million. Zuora, Inc. sees Q4 2021 EPS of ($0.06)-($0.05), versus the consensus of ($0.05). Zuora, Inc. sees Q4 2021 revenue of $239.2-240.2 million, versus the consensus of $296.96 million. Zuora, Inc. sees FY2021 EPS of ($0.14)-($0.13), versus the consensus of ($0.16). Zuora, Inc. sees FY2021 revenue of $62-63 million, versus the consensus of $74.29 million.

Tilly's, Inc. (NYSE: TLYS) 4.4% LOWER; reported Q3 EPS of $0.07, $0.07 better than the analyst estimate of $0.00. Revenue for the quarter came in at $140.3 million versus the consensus estimate of $130.94 million.

Ulta Salon (NASDAQ: ULTA) 2.8% HIGHER; reported Q3 EPS of $1.64, $0.15 better than the analyst estimate of $1.49. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.56 billion.

Smith & Wesson Brands (NASDAQ: SWBI) 2.5% HIGHER; reported Q2 EPS of $0.93, $0.30 better than the analyst estimate of $0.63. Revenue for the quarter came in at $248.7 million versus the consensus estimate of $222.99 million.